|
Vitamin D supplementation and clinical outcomes in cancer survivorship
|
23 October 2018 |
|
Vitamin D receptor as a marker of prognosis in oesophageal adenocarcinoma: a prospective cohort study
|
23 October 2018 |
|
Melatonin--a pleiotropic, orchestrating regulator molecule
|
22 October 2018 |
|
Melatonin: Pharmacology, Functions and Therapeutic Benefits
|
18 October 2018 |
|
Immune cells in the tumour: new routes of retinoids for chemoprevention and chemotherapeutics
|
18 October 2018 |
|
Strain-specific metastatic phenotypes in pheochromocytoma allograft mice
|
12 October 2018 |
|
Melatonin and its metabolite N1-acetyl-N2-formyl-5-methoxykynuramine (afmk) enhance chemosensitivity to gemcitabine in pancreatic carcinoma cells (PANC-1)
|
12 October 2018 |
|
Vitamin D deficiency is a cofactor of chemotherapy-induced mucocutaneous toxicity and dysgeusia
|
05 October 2018 |
|
The success and the challenge of all-trans retinoic acid in the treatment of cancer
|
05 October 2018 |
|
Vitamin D and Breast Cancer: Latest Evidence and Future Steps
|
05 October 2018 |